Back to Awarded Treatment Trials
Awarded Trial: 03-RC-005-2
Grant ID
03-RC-005-2
Illness
Schizophrenia
Primary Drug/Intervention
Azithromycin
Primary Dosage
600 mg/day
Secondary Drug Intervention
N/A
Secondary Dosage
N/A
Other Drug/Intervention
N/A
Other Dosage
N/A
Status
Completed
Investigator
Dickerson
Sample Size
56
Duration of Study Period for Each Subject
16 weeks
Outcome Measurements
PANSS
Results
Fifty six patients with schizophrenia who were seropositive for Toxoplasma gondii were randomized to receive adjunctive azithromycin or placebo (600 mg per day for 16 weeks). There was no significant improvement in psychiatric symptoms with this treatment.
Publication
N/A
Link
N/A
PI Name
Faith Dickerson
Degree
MD
Center
N/A
Institution
Sheppard Pratt Health System Inc.
Address
6501 N. Charles Street, P.O. Box 6815
City or Town
Baltimore
State or Province
MD
Zip or Postal Code
21285
Country
USA
Email Address
fdickerson@sheppardpratt.org